0401.HK
Wanjia Group Holdings Limited [0401.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0401.HK Stock Summary
In the News
0401.HK Financial details
Company Rating
Neutral
Market Cap
39.22M
Income
933K
Revenue
308.85M
Book val./share
0.2
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
198
Optionable
No
Shortable
Yes
Earnings
27 Nov 2023
P/E
15.68
Forward P/E
-
PEG
-1.54
P/S
0.37
P/B
0.41
P/C
2.1
P/FCF
-40.02
Quick Ratio
0.26
Current Ratio
2.02
Debt / Equity
0.18
LT Debt / Equity
0.12
-
-
EPS (TTM)
0
EPS next Y
-
EPS next Q
-
EPS this Y
-103.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
12.48%
Revenue Q/Q
11.75%
EPS Q/Q
-170.13%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
2%
ROE
-2%
ROC
0.01%
Gross Margin
34%
Oper. Margin
1%
Profit Margin
2%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.052-0.226
52W High
-
52W Low
-
RSI
48
Rel Volume
0.12
Avg Volume
169.02K
Volume
20K
Perf Week
-14.86%
Perf Month
5%
Perf Quarter
-
Perf Half Y
-21.25%
-
-
-
-
Beta
0.138
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.063
Change
0%
0401.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.68 | 0.46 | 0.2 | 0.28 | 0.31 | |
| Net income per share | -0.47 | -0.1 | -0.01 | -0.09 | 0 | |
| Operating cash flow per share | -0.33 | 0.1 | 0.01 | 0 | 0.02 | |
| Free cash flow per share | -0.39 | 0.05 | -0.01 | -0.01 | 0.01 | |
| Cash per share | 0.2 | 0.12 | 0.04 | 0.01 | 0.02 | |
| Book value per share | 0.6 | 0.75 | 0.3 | 0.23 | 0.21 | |
| Tangible book value per share | -0.39 | -0.09 | -0.04 | 0.04 | 0.04 | |
| Share holders equity per share | 0.6 | 0.75 | 0.3 | 0.23 | 0.21 | |
| Interest debt per share | 0.51 | 0.16 | 0.04 | 0.04 | 0.05 | |
| Market cap | 74.17M | 41.17M | 57.7M | 84.03M | 100.84M | |
| Enterprise value | 105.35M | 39.9M | 54.73M | 99.25M | 116.13M | |
| P/E ratio | -1.11 | -1.98 | -12.72 | -1.65 | 55.41 | |
| Price to sales ratio | 0.77 | 0.42 | 0.51 | 0.54 | 0.58 | |
| POCF ratio | -1.59 | 1.88 | 7.58 | 39.64 | 10.74 | |
| PFCF ratio | -1.35 | 3.7 | -13.28 | -17.29 | 18.43 | |
| P/B Ratio | 0.87 | 0.26 | 0.34 | 0.67 | 0.85 | |
| PTB ratio | 0.87 | 0.26 | 0.34 | 0.67 | 0.85 | |
| EV to sales | 1.09 | 0.41 | 0.48 | 0.64 | 0.67 | |
| Enterprise value over EBITDA | -2.61 | 32.92 | 6.63 | -2.87 | 22.31 | |
| EV to operating cash flow | -2.26 | 1.82 | 7.19 | 46.82 | 12.37 | |
| EV to free cash flow | -1.91 | 3.59 | -12.6 | -20.43 | 21.23 | |
| Earnings yield | -0.9 | -0.5 | -0.08 | -0.61 | 0.02 | |
| Free cash flow yield | -0.74 | 0.27 | -0.08 | -0.06 | 0.05 | |
| Debt to equity | 0.71 | 0.15 | 0.13 | 0.17 | 0.21 | |
| Debt to assets | 0.26 | 0.11 | 0.1 | 0.11 | 0.15 | |
| Net debt to EBITDA | -0.77 | -1.05 | -0.36 | -0.44 | 2.94 | |
| Current ratio | 1.08 | 2.15 | 2.02 | 1.79 | 2.02 | |
| Interest coverage | -3.38 | -0.85 | -1.56 | -36.23 | 2.22 | |
| Income quality | 0.73 | -1.07 | -2.22 | -0.04 | 3.82 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.26 | 0.15 | 0.14 | 0.14 | 0.14 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.42 | 0.43 | 0.43 | 0.28 | 0.28 | |
| Capex to operating cash flow | 0.18 | -0.49 | -1.57 | -3.29 | -0.42 | |
| Capex to revenue | -0.09 | -0.11 | -0.1 | -0.05 | -0.02 | |
| Capex to depreciation | -1.19 | -1.48 | -1.17 | -0.55 | -0.33 | |
| Stock based compensation to revenue | 0.04 | 0 | 0.02 | 0 | 0 | |
| Graham number | 2.52 | 1.29 | 0.23 | 0.68 | 0.12 | |
| ROIC | -0.31 | -0.05 | -0.01 | -0.29 | 0.02 | |
| Return on tangible assets | -0.51 | -0.18 | -0.04 | -0.37 | 0.01 | |
| Graham Net | -0.09 | 0 | 0 | -0.01 | 0 | |
| Working capital | 7.02M | 31.66M | 33.6M | 35.99M | 38.8M | |
| Tangible asset value | 39.89M | 69.33M | 74.58M | 75.07M | 71.13M | |
| Net current asset value | 7.02M | 10.77M | 14M | 17.73M | 23.65M | |
| Invested capital | 0.71 | 0.15 | 0.13 | 0.17 | 0.21 | |
| Average receivables | 88.61M | 42.83M | 28.46M | 44.31M | 53.33M | |
| Average payables | 56.88M | 14.7M | 8.33M | 20.44M | 28.18M | |
| Average inventory | 36.53M | 9.18M | 8.51M | 12.12M | 13.64M | |
| Days sales outstanding | 222.35 | 101.22 | 96.05 | 138.13 | 101.01 | |
| Days payables outstanding | 96.04 | 41.96 | 42.28 | 117.79 | 74.7 | |
| Days of inventory on hand | 49.55 | 37.89 | 48.1 | 53.16 | 39.48 | |
| Receivables turnover | 1.64 | 3.61 | 3.8 | 2.64 | 3.61 | |
| Payables turnover | 3.8 | 8.7 | 8.63 | 3.1 | 4.89 | |
| Inventory turnover | 7.37 | 9.63 | 7.59 | 6.87 | 9.24 | |
| ROE | -0.78 | -0.13 | -0.03 | -0.4 | 0.02 | |
| Capex per share | -0.06 | -0.05 | -0.02 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.08 | 0.16 | 0.07 | 0.15 | 0.17 | |
| Net income per share | 0 | 0 | 0 | 0.01 | -0.01 | |
| Operating cash flow per share | 0.01 | 0.02 | 0 | -0.01 | 0.02 | |
| Free cash flow per share | 0.01 | 0.02 | -0.01 | -0.01 | 0.02 | |
| Cash per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | |
| Book value per share | 0.2 | 0.2 | 0.21 | 0.21 | 0.2 | |
| Tangible book value per share | 0.14 | 0.02 | 0.13 | 0.04 | 0.03 | |
| Share holders equity per share | 0.2 | 0.2 | 0.21 | 0.21 | 0.2 | |
| Interest debt per share | 0 | 0.05 | 0 | 0.05 | 0.04 | |
| Market cap | 89.66M | 70.03M | 79.57M | 100.84M | 47.62M | |
| Enterprise value | 76.46M | 83.59M | 69.7M | 116.13M | 51.76M | |
| P/E ratio | -17.89 | -6.99 | 9.2 | 5.83 | -3.9 | |
| Price to sales ratio | 1.99 | 0.78 | 1.9 | 1.21 | 0.51 | |
| POCF ratio | 12.9 | 5.04 | -35.21 | -22.47 | 4.74 | |
| PFCF ratio | 13.43 | 5.14 | -20.2 | -16.35 | 4.74 | |
| P/B Ratio | 0.8 | 0.62 | 0.67 | 0.85 | 0.43 | |
| PTB ratio | 0.8 | 0.62 | 0.67 | 0.85 | 0.43 | |
| EV to sales | 1.7 | 0.93 | 1.67 | 1.39 | 0.55 | |
| Enterprise value over EBITDA | 95.04 | 28.2 | 18.51 | 8.29 | 60.68 | |
| EV to operating cash flow | 11 | 6.01 | -30.84 | -25.88 | 5.15 | |
| EV to free cash flow | 11.45 | 6.13 | -17.69 | -18.83 | 5.15 | |
| Earnings yield | -0.01 | -0.04 | 0.03 | 0.04 | -0.06 | |
| Free cash flow yield | 0.07 | 0.19 | -0.05 | -0.06 | 0.21 | |
| Debt to equity | 0 | 0.24 | 0 | 0.21 | 0.18 | |
| Debt to assets | 0 | 0.15 | 0 | 0.15 | 0.11 | |
| Net debt to EBITDA | -16.41 | 4.58 | -2.62 | 1.09 | 4.85 | |
| Current ratio | 1.66 | 1.66 | 2.02 | 2.02 | 1.72 | |
| Interest coverage | -1.23 | -1.5 | 1.23 | 5.99 | -5.6 | |
| Income quality | -5.55 | -5.55 | -1.04 | -1.04 | -3.3 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.11 | 0.06 | 0.17 | 0.09 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.3 | 0.3 | 0.28 | 0.28 | 0.28 | |
| Capex to operating cash flow | -0.04 | -0.02 | 0.74 | 0.37 | 0 | |
| Capex to revenue | -0.01 | 0 | -0.04 | -0.02 | 0 | |
| Capex to depreciation | -0.13 | -0.06 | -0.45 | -0.22 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.1 | 0.14 | 0.14 | 0.19 | 0.16 | |
| ROIC | -0.01 | -0.01 | 0.01 | 0.04 | -0.04 | |
| Return on tangible assets | -0.01 | -0.02 | 0.02 | 0.03 | -0.02 | |
| Graham Net | 0.01 | -0.01 | -0.01 | 0 | 0 | |
| Working capital | 32.32M | 32.32M | 38.8M | 38.8M | 35.38M | |
| Tangible asset value | 77.13M | 61.65M | 71.13M | 71.13M | 63.89M | |
| Net current asset value | 32.32M | 16.84M | 23.65M | 23.65M | 22.24M | |
| Invested capital | 0 | 0.24 | 0 | 0.21 | 0.18 | |
| Average receivables | 20.85M | 46.95M | 47.15M | 45.09M | 0 | |
| Average payables | 27.99M | 23.51M | 20.24M | 20.43M | 0 | |
| Average inventory | 15.34M | 16.02M | 14.33M | 12.63M | 0 | |
| Days sales outstanding | 83.25 | 52.11 | 90.72 | 51.78 | 54.85 | |
| Days payables outstanding | 66.74 | 33.37 | 57.23 | 40.31 | 41.62 | |
| Days of inventory on hand | 45.48 | 22.74 | 42.61 | 21.3 | 16 | |
| Receivables turnover | 1.08 | 1.73 | 0.99 | 1.74 | 1.64 | |
| Payables turnover | 1.35 | 2.7 | 1.57 | 2.23 | 2.16 | |
| Inventory turnover | 1.98 | 3.96 | 2.11 | 4.22 | 5.62 | |
| ROE | -0.01 | -0.02 | 0.02 | 0.04 | -0.03 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
0401.HK Frequently Asked Questions
What is Wanjia Group Holdings Limited stock symbol ?
Wanjia Group Holdings Limited is a HK stock and trading under the symbol 0401.HK
What is Wanjia Group Holdings Limited stock quote today ?
Wanjia Group Holdings Limited stock price is $0.063 today.
Is Wanjia Group Holdings Limited stock public?
Yes, Wanjia Group Holdings Limited is a publicly traded company.
Company Profile
- Volume Average 169.02K
- Market Capitalization 39.22M
- Employee 198
- CEO Mr. Jia Jun Wang
- Headquarters Kowloon,HK
- IPO Date 2013-10-11
-
Website
https://www.wanjia-gp.com 
Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
